Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupWolfgang R. Sperr, Peter Valent, Friedrich Wimazal et al.|Annals of Oncology|2009Cited by 117
The <i><scp>KIT</scp></i><scp>D</scp>816<scp>V</scp> allele burden predicts survival in patients with mastocytosis and correlates with the <scp>WHO</scp> type of the diseaseGregor Hoermann, Wolfgang R. Sperr, Georg Greiner et al.|Allergy|2014Cited by 103
Serum Tryptase Measurements in Patients with Myelodysplastic SyndromesWolfgang R. Sperr, Peter Valent, Birgitta Stehberger et al.|Leukemia & lymphoma/Leukemia and lymphoma|2002Cited by 84
Evaluation of the prognostic significance of Eosinophilia and Basophilia in a larger cohort of patients with myelodysplastic syndromesFriedrich Wimazal, Wolfgang R. Sperr, Ulrich Germing et al.|Cancer|2010Cited by 60
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromesFriedrich Wimazal, Peter Valent, Wolfgang R. Sperr et al.|Annals of Oncology|2008Cited by 46